Andere Sprachen Sunshine Biopharma, Inc.

Aktien

A2P2UN

US8677816014

SBFM

Realtime-Estimate Cboe BZX Andere Börsenplätze 20:41:52 29.04.2024			% 5 Tage	% 1. Jan.
0,841 ^USD	-11,47 %		-46,18 %	-96,50 %

12.04.	Sunshine Biopharma-Aktien brechen nach Ankündigung eines umgekehrten Aktiensplits ein	MT
28.03.	Sunshine Biopharma, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg, a Biosimilar of Neulasta	22.04.
Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product	19.04.
Top Premarket Decliners	19.04.
Sunshine Biopharma Announces Reverse Stock Split	15.04.
Sunshine Biopharma Shares Slump After Reverse Stock Split Announcement	12.04.
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	28.03.
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Sunshine Biopharma, Inc. announced that it has received $5 million in funding	28.03.
Thinking about buying stock in Mediwound, AeroVironment, Airship AI, Lyell Immunopharma, or Sunshine Biopharma?	06.03.
Sunshine Biopharma, Inc. announced that it expects to receive $0.01 million in funding	04.03.
Sunshine Biopharma, Inc. Announces Executive Changes	30.01.
Sunshine Biopharma Moves Principal Office to New York City	04.12.
Sunshine Biopharma, Inc. Announces Move Its Headquarters to New York City	04.12.
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	13.11.
Sunshine Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.
Jewish General Hospital Announces Termination of the Research Agreement with Sunshine Biopharma, Inc	02.11.
Sunshine Biopharma Gets Extension to Comply With Nasdaq Minimum Bid Price Rule	22.09.23
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%	11.08.23
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	10.08.23
Sunshine Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Sunshine Biopharma, Inc.

Aktien

A2P2UN

US8677816014

SBFM

Andere Sprachen

Filter